BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28492539)

  • 21. Increased expression of gap junction protein--connexin 32 in lymph node metastases of human ductal breast cancer.
    Kanczuga-Koda L; Sulkowska M; Koda M; Rutkowski R; Sulkowski S
    Folia Histochem Cytobiol; 2007; 45 Suppl 1():S175-80. PubMed ID: 18292829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different changes in expression and function of connexin 26 and connexin 32 during DNA synthesis and redifferentiation in primary rat hepatocytes using a DMSO culture system.
    Kojima T; Yamamoto M; Mochizuki C; Mitaka T; Sawada N; Mochizuki Y
    Hepatology; 1997 Sep; 26(3):585-97. PubMed ID: 9303487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental and protein kinase-dependent regulation of ovarian connexin mRNA and oocyte maturational competence in Atlantic croaker.
    Chang X; Patiño R; Thomas P; Yoshizaki G
    Gen Comp Endocrinol; 1999 Jun; 114(3):330-9. PubMed ID: 10336821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Connexin 32 and its derived homotypic gap junctional intercellular communication inhibit the migration and invasion of transfected HeLa cells via enhancement of intercellular adhesion.
    Yang J; Liu B; Wang Q; Yuan D; Hong X; Yang Y; Tao L
    Mol Med Rep; 2011; 4(5):971-9. PubMed ID: 21687945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propofol depresses the cytotoxicity of X-ray irradiation through inhibition of gap junctions.
    Zhao Y; Liu B; Wang Q; Yuan D; Yang Y; Hong X; Wang X; Tao L
    Anesth Analg; 2011 May; 112(5):1088-95. PubMed ID: 21415436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cx32 reverses epithelial-mesenchymal transition in doxorubicin-resistant hepatocellular carcinoma.
    Yu M; Han G; Qi B; Wu X
    Oncol Rep; 2017 Apr; 37(4):2121-2128. PubMed ID: 28260043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
    Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial connexin 32 regulates tissue factor expression induced by inflammatory stimulation and direct cell-cell interaction with activated cells.
    Okamoto T; Akita N; Hayashi T; Shimaoka M; Suzuki K
    Atherosclerosis; 2014 Oct; 236(2):430-7. PubMed ID: 25171777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer.
    Nishio S; Ushijima K; Yamaguchi T; Sasajima Y; Tsuda H; Kasamatsu T; Kage M; Ono M; Kuwano M; Kamura T
    Gynecol Oncol; 2014 Mar; 132(3):703-8. PubMed ID: 24486603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
    Asanuma H; Torigoe T; Kamiguchi K; Hirohashi Y; Ohmura T; Hirata K; Sato M; Sato N
    Cancer Res; 2005 Dec; 65(23):11018-25. PubMed ID: 16322251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.
    Fujimoto E; Sato H; Nagashima Y; Negishi E; Shirai S; Fukumoto K; Hagiwara H; Hagiwara K; Ueno K; Yano T
    Life Sci; 2005 Apr; 76(23):2711-20. PubMed ID: 15792837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gap junctional connexin messenger RNA expression in the ovine uterus and placenta: effects of estradiol-17β-treatment, early pregnancy stages, and embryo origin.
    Johnson ML; Redmer DA; Reynolds LP; Grazul-Bilska AT
    Domest Anim Endocrinol; 2017 Jan; 58():104-112. PubMed ID: 27835804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
    Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
    Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro.
    Lo YL; Wang W
    Chem Biol Interact; 2013 Oct; 205(3):188-97. PubMed ID: 23867903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connexin 32 expression reduces malignant phenotype in human A549 adenocarcinoma cells: Implication of Src involvement.
    Hada S; Sato H; Virgona N; Hagiwara H; Saito T; Suzuki K; Asano R; Yano T
    Oncol Rep; 2006 Nov; 16(5):1149-54. PubMed ID: 17016607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway.
    Li H; Lu Y; Pang Y; Li M; Cheng X; Chen J
    Biomed Pharmacother; 2017 Feb; 86():324-333. PubMed ID: 28011380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin I promotes cisplatin resistance via Cdk5 activation in cervical cancer.
    Li R; Liu GZ; Luo SY; Chen R; Zhang JX
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4533-41. PubMed ID: 26698249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cx32 formation and/or Cx32-mediated intercellular communication induces expression and function of tight junctions in hepatocytic cell line.
    Kojima T; Spray DC; Kokai Y; Chiba H; Mochizuki Y; Sawada N
    Exp Cell Res; 2002 May; 276(1):40-51. PubMed ID: 11978007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study.
    Tangjitgamol S; Ramirez PT; Sun CC; See HT; Jhingran A; Kavanagh JJ; Deavers MT
    Int J Gynecol Cancer; 2005; 15(4):646-56. PubMed ID: 16014119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.
    Ciaglia E; Abate M; Laezza C; Pisanti S; Vitale M; Seneca V; Torelli G; Franceschelli S; Catapano G; Gazzerro P; Bifulco M
    Int J Cancer; 2017 Feb; 140(4):959-972. PubMed ID: 27813087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.